Nanostructured lipid carriers and their application in drug delivery

International Journal of Biomedical Engineering and Technology

Volumn 2, Issue 2, 2009, Pages 152-171

  Khurana, Shelly ^a   Utreja, Puneet ^b   Tiwary, A K ^c   Jain, N K ^d   Jain, Subheet ^c  

^a Institute of Pharmaceutical Sciences and Engineering   (India)

^b Rayat School of Pharmacy   (India)

^c PUNJABI UNIVERSITY   (India)

^d DR H S GOUR UNIVERSITY   (India)

Author keywords

Applications; Characterisation; Nanostructured lipid carriers; NLC; Production techniques; SLN; Solid lipid nanoparticles

Indexed keywords

APPLICATIONS; NANOPARTICLES; TARGETED DRUG DELIVERY;

CARRIER SYSTEMS; CHARACTERISATION; DRUG DELIVERY SYSTEM; DRUG MOLECULES; NANOSTRUCTURED LIPID CARRIER (NLC); NANOSTRUCTURED LIPID CARRIERS; PRODUCTION TECHNIQUES; SOLID LIPID NANOPARTICLE (SLN);

CONTROLLED DRUG DELIVERY;

EID: 71049184592     PISSN: 17526418     EISSN: 17526426     Source Type: Journal    
DOI: 10.1504/IJBET.2009.022913     Document Type: Article

References (76)

1. Anger, S., Caldwell, K., Niehus, H. and Muller, R.H. (1999) 'High resolution determination of 20 nm colloidal gold particles by sedimentation field flow fractionation', Pharm. Res., Vol. 16, pp.1743-1747.
2. Bekerman, T., Golenser, J. and Domb, A. (2004) 'Cyclosporine nanoparticulate lipospheres for oral administration', J. Pharm Sci. Vol. 93, No. 5, pp.1264-1270.
3. Borgia, S.L., Regehly, M., Sivaramakrishnan, R., Mehnert, W., Korting, H.C., Danker, K., Roder, B., Kramer, K.D. and Schafer-Korting, M. (2005) 'Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy', J. Control. Release, Vol. 110, pp.151-163.
4. Bunjes, H., Westesen, K. and Koch, M.H.J. (1996) 'Crystallization tendency and polymorphic transitions in triglycerides nanoparticles', Int. J. Pharm., Vol. 129, pp.159-173.
5. Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S. and Saettone, M.F. (2002) 'Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin', Int. J. Pharm., Vol. 238, pp.241-245.
6. Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G.P. and Gasco, M.R. (2003) 'Duodenal administration of SLN loaded with different percentages of tobramycin', J. Pharm. Sci., Vol. 92, No. 5, pp.1085-1094.
7. Castelli, F., Puglia, C., Sarpietro, M.G., Rizza, L. and Bonina, F. (2005) 'Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry', Int. J. Pharm., Vol. 304, Nos. 1-2, pp.231-238.
8. Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H. and Yang, X. (2006) 'Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting', J. Control. Release, Vol. 110, No. 2, pp.296-306.
9. Dingler, A. and Gohla, S. (2002) 'Production of solid lipid nanoparticles (SLN): Scaling up feasibilities', J. Microencapsul., Vol. 19, No. 1, pp.11-16.
10. Garcia-Fuentes, M., Alonso, M.J. and Torres, D. (2005a) 'Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures', J. Colloid Interface Sci., Vol. 285, No. 2, pp.590-598.
11. Garcia-Fuentes, M., Prego, C., Torres, D. and Alonso, M.J. (2005b) 'A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery', Eur. J. Pharm. Sci., Vol. 25, No. 1, pp.133-143.
12. Giddings, J.C. (1993) 'Field flow fractionation: Analysis of macromolecular, colloidal, and particulate mater', Science, Vol. 260, pp.1456-1465.
13. Hu, F.Q., Jiang, S.P., Du, Y.Z., Yuan, H., Ye, Y.Q. and Zeng, S. (2005) 'Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system', Colloids Surf. B. Biointerfaces, Vol. 45, pp.167-173.
14. Hu, F.Q., Jiang, S.P., Du, Y.Z., Yuan, H., Ye, Y.Q. and Zeng, S. (2006) 'Preparation and characteristics of monostearin nanostructured lipid carriers', Int. J. Pharm., Vol. 314, No. 1, pp.83-89.
15. Jain, S., Jain, S. and Jain, N.K. (2001) 'Transfersomes: A novel carrier for effective transdermal drug delivery', in Jain, N.K. (Ed.): Advances in Controlled and Novel Drug Delivery, CBS publishers and Distributors, pp.18, 426-451.
16. Jain, S., Umamaheshwari, R.B., Bhadra, D. and Jain, N.K. (2004) 'Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent', Ind. J. Pharm. Sci., Vol. 66, No. 1, pp.72-81.
17. Jain, S.K., Chourasia, M.K., Masuriha, R., Soni, V., Jain, A., Jain, N.K. and Gupta, Y. (2005) 'Solid Lipid Nanoparticles bearing flurbiprofen for transdermal delivery', Drug Deliv., Vol. 12, No. 4, pp.207-215.
18. Jain, S., Tiwary, A.K. and Jain, N.K. (2006) 'Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action', Current Drug Delivery, Vol. 3, No. 2, pp.157-166.
19. Jenning, V., Thunemann, A.F. and Gohla, S.H. (2000a) 'Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids', Int. J. Pharm., Vol. 199, No. 2, pp.167-177.
20. Jenning, V., Schafer-Korting, M. and Gohla, S. (2000b) 'Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties', J. Control. Release, Vol. 66, Nos. 2-3, pp.115-126.
21. Jenning, V., Lippacher, A. and Gohla, S.H. (2002) 'Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization', J. Microencapsul., Vol. 19, No. 1, pp.1-10.
22. Jores, K., Haberland, A., Wartewig, S., Mader, K. and Mehnert, W. (2005) 'Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy', Pharm Res., Vol. 22, No. 11, pp.1887-1897.
23. Jores, K., Mehnert, W. and Mader, K. (2003) 'Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: A nuclear magnetic resonance and electron spin resonance study', Pharm Res., Vol. 20, No. 8, pp.1274-1283.
24. Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C. and Mader, K. (2004) 'Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy', J. Control. Release, Vol. 95, No. 2, pp.217-227.
25. Joshi, M. and Patravale, V. (2006) 'Formulation and evaluation of nanostructured lipid carrier (NLC)-based Gel of valdecoxib', Drug Dev. Ind. Pharm., Vol. 32, No. 8, pp.911-918.
26. Kawashima, Y., Yamamoto, H., Takeuchi, H., Hino, T. and Niwa, T. (1998) 'Properties of a peptide containing DL - lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods', Eur. J. Pharm. Biopharm., Vol. 45, pp.41-48.
27. Liedtke, S., Wissing, S., Muller, R.H. and Mader, K. (2000) 'Influence of high pressure homogenisation equipment on nanodispersions characteristics', Int. J. Pharm., Vol. 196, pp.183-185.
28. Lippacher, A., Muller, R.H. and Mader, K. (2000) 'Investigation on the viscoelastic properties of lipid based colloidal drug carriers', Int. J. Pharm., Vol. 196, pp.227-230.
29. Lippacher, A., Muller, R.H. and Mader, K. (2001) 'Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles', Int. J. Pharm., Vol. 214, pp.9-12.
30. Lippacher, A., Muller, R.H. and Mader, K. (2004) 'Liquid and semisolid SLN dispersions for topical application: Rheological characterization', Eur. J. Pharm. Biopharm., Vol. 58, No. 3, pp.561-567.
31. Liu, W., Yang, X.L., Zhu, Y.L., Chen, H.B. and Xu, H.B. (2005) 'Nanostructured lipid carriers as vehicles for transdermal iontophoretic drug delivery, Engineering in Medicine and Biology Society', IEEE-EMBS 27th Annual International Conference, pp.1236-1239.
32. Lockman, P.R., Mumper, R.J., Khan, M.A. and Allen, D.D. (2002) 'Nanoparticle technology for drug delivery across the blood brain barrier', Drug Dev. Ind Pharm., Vol. 28, No. 1, pp.1-12.
33. Maia, C.S., Mehnert, W. and Schafer-Korting, M. (2000) 'Solid lipid nanoparticles as drug carriers for topical glucocorticoids', Int. J. Pharm., Vol. 196, No. 2, pp. 165-167.
34. Manjunath, K. and Venkateswarlu, V. (2005) 'Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration', J. Control. Release, Vol. 107, No. 2, pp.215-228.
35. Mehnert, W. and Mader, K. (2001) 'Solid lipid nanoparticles: Production, characterization and applications', Adv. Drug Deliv. Rev., Vol. 47, No. 2, pp.165-196.
36. Muhlen, A.Z. and Mehnert, W. (1998) 'Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles',Pharmazie, Vol. 53, p.552.
37. Muller, R.H. and Lucks, J.S. (1996) 'Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN)', European Patent EP0605497, March.
38. Müller, R.H. and Keck, C.M. (2004) 'Drug delivery to the brain-realization by novel drug carriers', J Nanosci. Nanotechnol. Vol. 4, No. 5, pp.471-483.
39. Muller, R.H. and Dingler, A. (1998) 'The next generation after the liposomes: Solid lipid nanoparticles (SLN/Lipopearls) as dermal carrier in cosmetics', Eur. Cosmet., Vols. 7-8, pp.19-26.
40. Muller, R.H., Lucks, J.S., Schwarz, C., Zur Muhlen, A., Weyhers, H., Freitas, C. and Ruhl, D., (1995) 'Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery', Eur. J. Pharm. Biopham., Vol. 41, No. 1, pp.62-69.
41. Muller, R.H., Mader, K. and Gohla, S. (2000a) 'Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art', Eur. J. Pharm. Biopharm., Vol. 50, No. 1, pp. 161-177.
42. Muller, R.H., Mader, K., Lippacher, A. and Jenning, V. (2000b) 'Solid-liquid (semi-solid) lipid particles and method of producing highly concentrated lipid particle dispersion', German Patent Application, Vol. 199, No. 45, pp.203.2.
43. Muller, R.H., Radtke, M. and Wissing, S.A. (2002a) 'Nanostructured lipid matrices for improved microencapsulation of drugs', Int. J. Pharm. Vol. 242, Nos. 1-2, pp.121-128.
44. Muller, R.H., Radtke, M. and Wissing, S.A., (2002b) 'Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations', Adv. Drug Deliv. Rev., Vol. 54, Suppl. 1, pp.S131-155.
45. Puglia, C., Filosa, R., Peduto, A., de Caprariis, P., Rizza, L., Bonina, F. and Blasi, P. (2006) 'Evaluation of alternative strategies to optimize ketorolac transdermal delivery', AAPS Pharm. SciTech., Vol. 7, No. 3, Article 64, pp.E1-E9.
46. Radomska-Soukharev, A. and Muller, R.H. (2006) 'Chemical stability of lipid excipients in SLN-production of test formulations, characterization and short-term stability', Pharmazie, Vol. 61, No. 5, pp.425-430.
47. Radtke, M. and Muller, R.H. (2001) 'Nanostructured lipid drug carriers', New Drugs, Vol. 2, pp.48-52.
48. Radtke, M., Souto, E.B. and Muller, R.H. (2005) 'Nanostructured lipid carriers: A novel generation of solid lipid drug carriers', Pharm. Tech. Eur., Vol. 17, No. 4, pp.45-50.
49. Ricci, M., Puglia, C., Bonina, F., Di Giovanni, C., Giovagnoli, S. and Rossi, C. (2005) 'Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): In vitro and in vivo studies', J Pharm. Sci., Vol. 94, No. 5, pp. 1149-1159.
50. Saupe, A., Gordon, K.C. and Rades, T. (2006) 'Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy', Int. J. Pharm., Vol. 314, pp.56-62.
51. Schwarz, C., Freitas, C., Mehnert, W. and Muller, R.H. (1995) 'Sterilization and physical stability of drug -free and etomidate-loaded solid lipid nanoparticles', Proc. Int. Symp. Control. Rel. Bioact. Mater., Vol. 22, pp.766-767.
52. Schwarz, C., Mehnert, W., Lucks, J.S. and Muller, R.H. (1994) 'Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization', J. Control. Release, Vol. 30, pp.83-96.
53. Siekmann, B. and Westesen, K. (1992) 'Submicron sized parenteral carrier systems based on solid lipids', Pharma. Pharmacol. Lett., Vol. 1, pp.123-126.
54. Siekmann, B. and Westesen, K. (1994) 'Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles', Colloids Surf B. Biointerfaces, Vol. 3, No. 3, pp.159-175.
55. Siostrom, B., Kaplum, A., Talmon, B. and Cabane, C. (1995) 'Structure of nanoparticles prepared from oil - in - water emulsions', Pharm. Res. Vol. 12, No. 1, pp.39-48.
56. Souto, E.B. and Muller, R.H. (2005) 'SLN and NLC for topical delivery of ketoconazole', J. Microencapsul., Vol. 22, No. 5, pp.501-510.
57. Souto, E.B. and Muller, R. H. (2006) 'The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents', Pharmazie, Vol. 61, No. 5, pp.431-437.
58. Souto, E.B., Gohla, S.H. and Muller, R.H. (2005) 'Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic medium', Pharmazie, Vol. 60, No. 9, pp.671-673.
59. Souto, E.B. and Muller, R.H. (2005) 'SLN and NLC for topical delivery of ketoconazole', J. Microencapsul., Vol. 22, No. 5, pp.501-510.
60. Souto, E.B., Wissing, S.A., Barbosa, C.M. and Muller, R.H. (2004a) 'Comparative study between the viscoelastic behaviors of different lipid nanoparticles formulations', J. Cosmet. Sci., Vol. 55, No. 5, pp.463-471.
61. Souto, E.B., Wissing, S.A., Barbosa, C.M. and Muller, R.H. (2004b) 'Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations', Eur. J. Pharm. Biopharm. Vol. 58, No. 1, pp.83-90.
62. Teeranachaideekul, V., Muller, R.H. and Junyaprasert, V.B. (2007a) 'Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) - Effects of formulation parameters on physicochemical stability', Int. J. Pharm., Vol. 340, pp. 198-206.
63. Teeranachaideekul, V., Souto, E.B., Junyaprasert, V.B., Rainer, H. and Muller, R.H. (2007b) 'Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10-Development, physicochemical characterization and in vitro release studies', Eur. J. Pharm. Biopahrm., Vol. 67, pp. 141-148.
64. Trotta, M., Debernardi, F. and Caputo, O. (2003) 'Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique', Int. J. Pharm., Vol. 257, Nos. 1-2, pp. 153-160.
65. Uner, M. (2006) 'Preparation, characterization and physico-chemical properties of solid lipid nanoparticles and nanostructured lipid carriers (NLC): Their benefits as colloidal systems', Pharmazie, Vol. 61, No. 5, pp.375-386.
66. Uner, M., Wissing, S.A., Yener, G. and Muller, R.H. (2005) 'Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate', Pharmazie, Vol. 60, No. 8, pp.577-582.
67. Videira, M.A., Botelho, M.F., Santos, A.C., Gouveia, L.F., de Lima, J.J. and Almeida, A.J. (2002) 'Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles', J. Drug Target., Vol. 10, No. 8, pp. 607-613.
68. Villalobos-Hernández, J.R. and Müller-Goymann, CC. (2006) 'Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: The synergistic interaction between organic and inorganic sunscreens at nanoscale', Int. J. Pharm., Vol. 322, pp.161-170.
69. Villalobos-Hernández, J.R. and Müller-Goymann, CC. (2007) 'In vitro erythernal UV-A protection factors of inorganic sunscreens distributed in aqueous media using carnauba wax-decyl oleate nanoparticles', Eur. J. Pharma. Biopharm., Vol. 65, pp.122-125.
70. Wang, J.X., Sun, X. and Zhang, Z.R. (2002) 'Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles', Eur. J. Pharm. Biopharm., Vol. 54, No. 3, pp.285 290.
71. Westesen, K. and Siekmann, B. (1997) 'Investigation of the gel formation of phospholipids stabilized solid lipid nanoparticles', Int. J. Pharm., Vol. 151, pp.35-45.
72. Wissing, S.A. and Muller, R.H. (2001) 'A novel solvent system based on tocopherol acetate incorporated into solid lipid nanoparticles', Int. J. Cosmet. Sci., Vol. 23, pp.233-243.
73. Wissing, S.A. and Muller, R.H. (2002) 'Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo penetration', J. Control. Release, Vol. 81, pp.225-233.
74. Wissing, S.A. and Muller, R.H. (2003) 'Cosmetic applications for solid lipid nanoparticles (SLN)' Int. J. Pharm., Vol. 254, pp.65-68.
75. Yang, S.C., Lu, L.F., Cai, Y., Zhu, J.B., Liang, B.W. and Yang, C.Z. (1999) 'Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain', J. Control. Release, Vol. 59, No. 3, pp.299-307.
76. 1H NMR', Pharmazie, Vol. 60, No. 7, pp.508-513.